Key result
Tobacco products promote atherosclerosis and vascular disease via systemic and coronary hemodynamic effects.
Why the study?
Despite the strong epidemiologic link between smoking and vascular disease, the pathophysiologic mechanisms of tobacco's deleterious cardiovascular effects remain incompletely understood.
This review summarizes the pathophysiologic mechanisms by which tobacco products exert acute and long-term deleterious hemodynamic effects on the cardiovascular system.
Answers are grounded in this paper and cite their sources.
Emphasizes tobacco avoidance in CV risk reduction; leaves open precise mechanisms for targeted research.
Tobacco product usage is the single most preventable cause of death in the United States. Smoking promotes atherosclerosis, producing disease in the coronary arteries, the aorta, the carotid and cerebral arteries and the large arteries in the peripheral circulation. The cardiovascular consequences of tobacco products have been the subject of intensive study for several decades. Despite the overwhelming epidemiologic association between smoking and vascular disease, the pathophysiologic mechanisms by which smoking exerts its deleterious effects remain incompletely understood. This review addresses the acute and long-term systemic and coronary hemodynamic effects of tobacco, with an emphasis of the impact on coronary blood flow and pathophysiologic mechanisms.
No takes yet. Share an insight, caveat, or question.
Lloyd W. Klein (2021) conducted a review in Cardiovascular disease. Tobacco products was evaluated. Tobacco products exert acute and long-term systemic and coronary hemodynamic effects that promote atherosclerosis and vascular disease through incompletely understood pathophysiologic mechanisms.
Synapse has enriched 10 related papers. Consider them for comparative context: